By Jannie van den Broek, Director Strategic Capabilities & Solutions at Amgen
The essence of value-driven care is putting patient-value central and focusing on what is really important to patients. If we start paying for value in healthcare, we remove the main reason for the unsustainability of our care – being paid per medical activity, i.e. an incentive based on volume – Read more why I find this so important and why this is a relevant theme to discuss in the 2021 Value Agenda working session.
Good treatment is treatment that is aligned with a patient's personal situation, which can be different for everyone. Healthcare professional and patient should be able to decide together what the most important treatment outcomes are for that person, and what the most suitable treatment is. They must also be able to discuss where the quality of this treatment is best. After all, does all care provided actually contribute to the functioning of people and their quality of life? And has all care still been proven effective?
We can only answer this if we focus on treatment outcomes and are funded accordingly. Currently, care provided is still reimbursed per activity or, but that has to change, as it leads to volume incentives and not to quality incentives. This requires a completely different way of looking at delivery of care, but is really necessary to make the healthcare system future-proof. After all, if you focus on treatment outcomes and are paid accordingly, this results in greater effectiveness and efficiency. According to VBHC Center Europe, which has guided over 200 Value Based Healthcare initiatives, the total cost savings will amount to around 1 billion euros in 2019 (1)†
In short, the result is more effectiveness and efficiency that benefits the patient. Better care for lower costs. While paying for outcomes may seem simple on paper, it is not so easy to implement in practice. For example, there is no uniformity in data, the outcomes are not yet defined in the same way everywhere, the IT systems differ and confidence still needs to grow that sharing outcomes is not intended to judge one another, but to start continuous improvement cycles.
And how do you finance prevention or other innovative care solutions such as e-health? Who should take the lead? Insurers? Doctors? Government? Associations? Life Sciences & Health companies? I firmly believe that future-proof care is important to all of us! It is a shared responsibility and so we will have to stand shoulder to shoulder.
That is why I am so happy that on October 5th , together with 25 other decision-makers in healthcare, we will be discussing the theme 'Paying for outcomes'. Together we move forward, give the Value Agenda 2021 a boost and determine what still needs to be done to get paid for outcomes.
I look forward to the discussions!
Do you have any questions or comments about this article? Let me know.